SlideShare a Scribd company logo
1 of 15
CASE PRESENTATION ON
EPILEPSY
SUBJECTIVE EVIDENCE
PATIENT DETAILS
• NAME : Abc
• AGE : 49
• SEX : Male
• IP.NO : 81118
• DEPT. : Male general ward
• REASON FOR ADMISSION : c/o Generalized
weakness with slurred speech since 3
days,fatigue,fever on and off from 3
days,constipation,cough,expectoration
• PAST MEDICAL HISTORY : k/c/o Epilepsy
• PAST MEDICATION HISTORY : Eptoin 100mg
OBJECTIVE EVIDENCE
LABORATORY INVESTIGATION:
DATE 2/11 3/11/ 4/11 5/11 6/11 7/11 8/11
TEMP. 99.6 99.6 99.6 98.2 98.1 98.1 98.1
B.P.(mm
of Hg)
170/110 170/110 160/110 120/100 120/110 130/90 130/90
PULSE 80
BLOOD COUNT TEST
• Haemoglobin : 13.6g/dL
• Platelets : 1,68,000
Differential leukocyte count
• Lymphocytes : 26%
• Basophils : 0%
• Eosinophils : 1%
• Monocytes : 2%
RENAL FUNCTION TEST
• Urea : 22 mg%
• Serum Creatinine : 1.2 mg%
ELECTROLYTES TEST
• Sodium : 123 m.Eq/L
• Potassium : 4.8 m.Eq/L
• Chloride : 91 m.Eq/L
OTHER INVESTIGATIONS
• Chest X ray
• CT scan
• EEG
ASSESSMENT
Based on Subjective and Objective evidence
the patient was assessed with “HEAD INJURY
with EPILEPSY “ and “HYPERTENSION”
GOALS OF TREATMENT
• To releive signs and symptoms
• To control or reduce the frequency and
severity of seizures
• To improve the patient compliance
• Maintaining or restoring quality of life
DRUG CHART
BRAND NAME GENERIC
NAME
FREQ DOSE 2/11 3/11 4/11 5/11 6/11
T.Leripril Levetiraceta
m
1-0-1 500mg yes yes yes yes yes
T.Eptoin Phenytoin 1-1-1 100mg yes yes yes yes yes
T.Amlodipine Amlodipine 1-0-1 5mg yes yes yes yes yes
Inj.Ceftriaxone Ceftriaxone 1-0-1 1gm yes yes yes yes -
T.Paracetamol Acetaminop
hen
1-1-1 600mg yes yes yes yes -
T.Cusena Docusate
Na+Senna
0-0-2 100+80m
g
yes yes yes - -
IVF NS Normal
saline
SOS 500ml - yes yes Yes yes
T.Hifenac.MR Aceclofenac
+Paracetamo
l
1-0-1 100+650
mg
- - - yes yes
T.Nitrofurantoi Nitrofurantoi 1-0-1 100mg - - - - yes
DRUG INTERACTIONS
• Amlodipine + Phenytoin
Amlodipine will increase the level or effect of
phenytoin by affecting hepatic /intestinal
enzyme CYP3A4 metabolism.
• Levetiracetam + Acetaminophen
Levetiracetam decreases levels of
acetaminophen by increasing metabolism.
• Phenytoin + Acetaminophen
Phenytoin decreases levels of acetaminophen by
increasing metabolism
PHARMACIST INTERVENTION
• No proper treatment is given to releive cough
and expectoration.
• Drug duplication is found (paracetamol and
T.Hifenac
• No proper inference is given regarding
investigations done like chest x ray and EEG.
PATIENT COUNSELLING
• Take medications regularly and properly as indicated.
• Avoid more salt intake into your diet.
• Drink plenty of water to keep body hydrated.
• Get enough sleep.
• Intake Ketogenic diet which involces low in carbohydrates and high
in protein and fats.
• Try relaxation or slow breathing exercises when anxious or if you
begin to hyperventilate.
• Avoid white products like white sugar,table salt,white rice
• Take Epsom salt bath (2/3 times per week)
• Do exerises regularly like walking for 45mins but stop and rest if you
feel tired
• Manage stress and avoid stressful situstions.
THANK YOU

More Related Content

Similar to CASE PRESENTATION ON EPILEPSY.pptx epilepsy is a disorder

Anaesthesia Management Thyroid by Dr. Animesh
Anaesthesia Management Thyroid by Dr. AnimeshAnaesthesia Management Thyroid by Dr. Animesh
Anaesthesia Management Thyroid by Dr. Animesh
19anisingh
 

Similar to CASE PRESENTATION ON EPILEPSY.pptx epilepsy is a disorder (20)

Conn’s syndrome
Conn’s syndromeConn’s syndrome
Conn’s syndrome
 
LRTI 1.pptx
LRTI 1.pptxLRTI 1.pptx
LRTI 1.pptx
 
Case presentation on tuberculosis and k
Case presentation on tuberculosis  and kCase presentation on tuberculosis  and k
Case presentation on tuberculosis and k
 
CASE PRESENTATION ON JAUNDICE
CASE PRESENTATION ON JAUNDICECASE PRESENTATION ON JAUNDICE
CASE PRESENTATION ON JAUNDICE
 
rkcasepresentation-170124170153 (2).pdf
rkcasepresentation-170124170153 (2).pdfrkcasepresentation-170124170153 (2).pdf
rkcasepresentation-170124170153 (2).pdf
 
Nuclear Medicine Procedures-2
Nuclear Medicine Procedures-2Nuclear Medicine Procedures-2
Nuclear Medicine Procedures-2
 
Case study (1)
Case study (1)Case study (1)
Case study (1)
 
CASE PRESENTATION ON DRUG INDUCED GASTROINTESTINAL BLEED.pptx
CASE PRESENTATION ON DRUG INDUCED GASTROINTESTINAL BLEED.pptxCASE PRESENTATION ON DRUG INDUCED GASTROINTESTINAL BLEED.pptx
CASE PRESENTATION ON DRUG INDUCED GASTROINTESTINAL BLEED.pptx
 
Theophylline toxicity
Theophylline toxicityTheophylline toxicity
Theophylline toxicity
 
Case-based approach in parenteral fluid therapy
Case-based approach in parenteral fluid therapyCase-based approach in parenteral fluid therapy
Case-based approach in parenteral fluid therapy
 
Lupus nephritis with pregnancy
Lupus nephritis with pregnancyLupus nephritis with pregnancy
Lupus nephritis with pregnancy
 
TEF PPT
TEF PPTTEF PPT
TEF PPT
 
acute pancreatitis.pptx
acute pancreatitis.pptxacute pancreatitis.pptx
acute pancreatitis.pptx
 
case histories in dengue fever
case histories in dengue fevercase histories in dengue fever
case histories in dengue fever
 
SOAP ANALYSIS- PHARM.D.pptx
SOAP ANALYSIS- PHARM.D.pptxSOAP ANALYSIS- PHARM.D.pptx
SOAP ANALYSIS- PHARM.D.pptx
 
Anaesthesia Management Thyroid by Dr. Animesh
Anaesthesia Management Thyroid by Dr. AnimeshAnaesthesia Management Thyroid by Dr. Animesh
Anaesthesia Management Thyroid by Dr. Animesh
 
Case 2 em
Case 2 emCase 2 em
Case 2 em
 
Case Study On ACS.pptx
Case Study On ACS.pptxCase Study On ACS.pptx
Case Study On ACS.pptx
 
Polymicrobial lung abscess.pptx
Polymicrobial lung abscess.pptxPolymicrobial lung abscess.pptx
Polymicrobial lung abscess.pptx
 
Thrombus everywhere
Thrombus everywhereThrombus everywhere
Thrombus everywhere
 

More from Bindu238662

CVS 03 11 (1).pptfffghughjijghjjuffffjjhgg
CVS 03 11 (1).pptfffghughjijghjjuffffjjhggCVS 03 11 (1).pptfffghughjijghjjuffffjjhgg
CVS 03 11 (1).pptfffghughjijghjjuffffjjhgg
Bindu238662
 
RDNA TECQ.pptx ghfgdfhgjgjgjgghghgghbhbh
RDNA TECQ.pptx ghfgdfhgjgjgjgghghgghbhbhRDNA TECQ.pptx ghfgdfhgjgjgjgghghgghbhbh
RDNA TECQ.pptx ghfgdfhgjgjgjgghghgghbhbh
Bindu238662
 
CVS 04 12.ppt fgftfhjhjhjghggghghjjhjhjhjh
CVS 04 12.ppt fgftfhjhjhjghggghghjjhjhjhjhCVS 04 12.ppt fgftfhjhjhjghggghghjjhjhjhjh
CVS 04 12.ppt fgftfhjhjhjghggghghjjhjhjhjh
Bindu238662
 
antihypertensiveagents.pptx vdscscsdfdfsfds
antihypertensiveagents.pptx vdscscsdfdfsfdsantihypertensiveagents.pptx vdscscsdfdfsfds
antihypertensiveagents.pptx vdscscsdfdfsfds
Bindu238662
 
polarimetry-110527042535-phpap hghygytrfgfhghghghghghghghp01.pptx
polarimetry-110527042535-phpap hghygytrfgfhghghghghghghghp01.pptxpolarimetry-110527042535-phpap hghygytrfgfhghghghghghghghp01.pptx
polarimetry-110527042535-phpap hghygytrfgfhghghghghghghghp01.pptx
Bindu238662
 
Candidiasis.ppt gdfesfsdxsfertrgfgdvscsdsdsd
Candidiasis.ppt gdfesfsdxsfertrgfgdvscsdsdsdCandidiasis.ppt gdfesfsdxsfertrgfgdvscsdsdsd
Candidiasis.ppt gdfesfsdxsfertrgfgdvscsdsdsd
Bindu238662
 
ACUTE PANCREATITIS.pptx vgcfgvhbhbjbhbhjg
ACUTE PANCREATITIS.pptx vgcfgvhbhbjbhbhjgACUTE PANCREATITIS.pptx vgcfgvhbhbjbhbhjg
ACUTE PANCREATITIS.pptx vgcfgvhbhbjbhbhjg
Bindu238662
 
EXACT PROJECT PRESENTATION DM.pgefuggsggegeggehgegptx
EXACT PROJECT PRESENTATION DM.pgefuggsggegeggehgegptxEXACT PROJECT PRESENTATION DM.pgefuggsggegeggehgegptx
EXACT PROJECT PRESENTATION DM.pgefuggsggegeggehgegptx
Bindu238662
 
ANAND KRISHNA0001.pptx dfdguhjkjkjkjhjhgh
ANAND KRISHNA0001.pptx dfdguhjkjkjkjhjhghANAND KRISHNA0001.pptx dfdguhjkjkjkjhjhgh
ANAND KRISHNA0001.pptx dfdguhjkjkjkjhjhgh
Bindu238662
 
project final.pptx ffdfdgfhghjfghghghghghgh
project final.pptx ffdfdgfhghjfghghghghghghproject final.pptx ffdfdgfhghjfghghghghghgh
project final.pptx ffdfdgfhghjfghghghghghgh
Bindu238662
 
MI (4).ppt myocardial infarction is a type of heart disease
MI (4).ppt myocardial infarction is a type of heart diseaseMI (4).ppt myocardial infarction is a type of heart disease
MI (4).ppt myocardial infarction is a type of heart disease
Bindu238662
 
BINDU00001.pptx is a ppt of a disease named
BINDU00001.pptx is a ppt of a disease namedBINDU00001.pptx is a ppt of a disease named
BINDU00001.pptx is a ppt of a disease named
Bindu238662
 
alcohol depenDENCE IS A DISORDER WHERE A ERSON IS ADDICTED TO ALCOHOL
alcohol depenDENCE IS A DISORDER WHERE A ERSON IS ADDICTED TO ALCOHOLalcohol depenDENCE IS A DISORDER WHERE A ERSON IS ADDICTED TO ALCOHOL
alcohol depenDENCE IS A DISORDER WHERE A ERSON IS ADDICTED TO ALCOHOL
Bindu238662
 
MI is cardiovascular disorder with infarction in cardiac muscles which leads ...
MI is cardiovascular disorder with infarction in cardiac muscles which leads ...MI is cardiovascular disorder with infarction in cardiac muscles which leads ...
MI is cardiovascular disorder with infarction in cardiac muscles which leads ...
Bindu238662
 
COPD is a lung disorder which involves the lung obstruction for airway and br...
COPD is a lung disorder which involves the lung obstruction for airway and br...COPD is a lung disorder which involves the lung obstruction for airway and br...
COPD is a lung disorder which involves the lung obstruction for airway and br...
Bindu238662
 
minimized asthma project is a project related to asthma treatment through GIN...
minimized asthma project is a project related to asthma treatment through GIN...minimized asthma project is a project related to asthma treatment through GIN...
minimized asthma project is a project related to asthma treatment through GIN...
Bindu238662
 
project ppt for 4th month.pptx
project ppt for 4th month.pptxproject ppt for 4th month.pptx
project ppt for 4th month.pptx
Bindu238662
 
ALTERED GENE FUNCTION.pptx
ALTERED GENE FUNCTION.pptxALTERED GENE FUNCTION.pptx
ALTERED GENE FUNCTION.pptx
Bindu238662
 

More from Bindu238662 (20)

CVS 03 11 (1).pptfffghughjijghjjuffffjjhgg
CVS 03 11 (1).pptfffghughjijghjjuffffjjhggCVS 03 11 (1).pptfffghughjijghjjuffffjjhgg
CVS 03 11 (1).pptfffghughjijghjjuffffjjhgg
 
RDNA TECQ.pptx ghfgdfhgjgjgjgghghgghbhbh
RDNA TECQ.pptx ghfgdfhgjgjgjgghghgghbhbhRDNA TECQ.pptx ghfgdfhgjgjgjgghghgghbhbh
RDNA TECQ.pptx ghfgdfhgjgjgjgghghgghbhbh
 
CVS 04 12.ppt fgftfhjhjhjghggghghjjhjhjhjh
CVS 04 12.ppt fgftfhjhjhjghggghghjjhjhjhjhCVS 04 12.ppt fgftfhjhjhjghggghghjjhjhjhjh
CVS 04 12.ppt fgftfhjhjhjghggghghjjhjhjhjh
 
antihypertensiveagents.pptx vdscscsdfdfsfds
antihypertensiveagents.pptx vdscscsdfdfsfdsantihypertensiveagents.pptx vdscscsdfdfsfds
antihypertensiveagents.pptx vdscscsdfdfsfds
 
polarimetry-110527042535-phpap hghygytrfgfhghghghghghghghp01.pptx
polarimetry-110527042535-phpap hghygytrfgfhghghghghghghghp01.pptxpolarimetry-110527042535-phpap hghygytrfgfhghghghghghghghp01.pptx
polarimetry-110527042535-phpap hghygytrfgfhghghghghghghghp01.pptx
 
Candidiasis.ppt gdfesfsdxsfertrgfgdvscsdsdsd
Candidiasis.ppt gdfesfsdxsfertrgfgdvscsdsdsdCandidiasis.ppt gdfesfsdxsfertrgfgdvscsdsdsd
Candidiasis.ppt gdfesfsdxsfertrgfgdvscsdsdsd
 
ACUTE PANCREATITIS.pptx vgcfgvhbhbjbhbhjg
ACUTE PANCREATITIS.pptx vgcfgvhbhbjbhbhjgACUTE PANCREATITIS.pptx vgcfgvhbhbjbhbhjg
ACUTE PANCREATITIS.pptx vgcfgvhbhbjbhbhjg
 
EXACT PROJECT PRESENTATION DM.pgefuggsggegeggehgegptx
EXACT PROJECT PRESENTATION DM.pgefuggsggegeggehgegptxEXACT PROJECT PRESENTATION DM.pgefuggsggegeggehgegptx
EXACT PROJECT PRESENTATION DM.pgefuggsggegeggehgegptx
 
COPD chronic obstructive pulmonary disease
COPD chronic obstructive pulmonary diseaseCOPD chronic obstructive pulmonary disease
COPD chronic obstructive pulmonary disease
 
ANAND KRISHNA0001.pptx dfdguhjkjkjkjhjhgh
ANAND KRISHNA0001.pptx dfdguhjkjkjkjhjhghANAND KRISHNA0001.pptx dfdguhjkjkjkjhjhgh
ANAND KRISHNA0001.pptx dfdguhjkjkjkjhjhgh
 
project final.pptx ffdfdgfhghjfghghghghghgh
project final.pptx ffdfdgfhghjfghghghghghghproject final.pptx ffdfdgfhghjfghghghghghgh
project final.pptx ffdfdgfhghjfghghghghghgh
 
MI (4).ppt myocardial infarction is a type of heart disease
MI (4).ppt myocardial infarction is a type of heart diseaseMI (4).ppt myocardial infarction is a type of heart disease
MI (4).ppt myocardial infarction is a type of heart disease
 
BINDU00001.pptx is a ppt of a disease named
BINDU00001.pptx is a ppt of a disease namedBINDU00001.pptx is a ppt of a disease named
BINDU00001.pptx is a ppt of a disease named
 
CASE PRESENTATION - Copy.pptx TYPE OF ANEMIA
CASE PRESENTATION - Copy.pptx TYPE OF ANEMIACASE PRESENTATION - Copy.pptx TYPE OF ANEMIA
CASE PRESENTATION - Copy.pptx TYPE OF ANEMIA
 
alcohol depenDENCE IS A DISORDER WHERE A ERSON IS ADDICTED TO ALCOHOL
alcohol depenDENCE IS A DISORDER WHERE A ERSON IS ADDICTED TO ALCOHOLalcohol depenDENCE IS A DISORDER WHERE A ERSON IS ADDICTED TO ALCOHOL
alcohol depenDENCE IS A DISORDER WHERE A ERSON IS ADDICTED TO ALCOHOL
 
MI is cardiovascular disorder with infarction in cardiac muscles which leads ...
MI is cardiovascular disorder with infarction in cardiac muscles which leads ...MI is cardiovascular disorder with infarction in cardiac muscles which leads ...
MI is cardiovascular disorder with infarction in cardiac muscles which leads ...
 
COPD is a lung disorder which involves the lung obstruction for airway and br...
COPD is a lung disorder which involves the lung obstruction for airway and br...COPD is a lung disorder which involves the lung obstruction for airway and br...
COPD is a lung disorder which involves the lung obstruction for airway and br...
 
minimized asthma project is a project related to asthma treatment through GIN...
minimized asthma project is a project related to asthma treatment through GIN...minimized asthma project is a project related to asthma treatment through GIN...
minimized asthma project is a project related to asthma treatment through GIN...
 
project ppt for 4th month.pptx
project ppt for 4th month.pptxproject ppt for 4th month.pptx
project ppt for 4th month.pptx
 
ALTERED GENE FUNCTION.pptx
ALTERED GENE FUNCTION.pptxALTERED GENE FUNCTION.pptx
ALTERED GENE FUNCTION.pptx
 

Recently uploaded

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
MateoGardella
 

Recently uploaded (20)

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 

CASE PRESENTATION ON EPILEPSY.pptx epilepsy is a disorder

  • 2. SUBJECTIVE EVIDENCE PATIENT DETAILS • NAME : Abc • AGE : 49 • SEX : Male • IP.NO : 81118 • DEPT. : Male general ward
  • 3. • REASON FOR ADMISSION : c/o Generalized weakness with slurred speech since 3 days,fatigue,fever on and off from 3 days,constipation,cough,expectoration • PAST MEDICAL HISTORY : k/c/o Epilepsy • PAST MEDICATION HISTORY : Eptoin 100mg
  • 4. OBJECTIVE EVIDENCE LABORATORY INVESTIGATION: DATE 2/11 3/11/ 4/11 5/11 6/11 7/11 8/11 TEMP. 99.6 99.6 99.6 98.2 98.1 98.1 98.1 B.P.(mm of Hg) 170/110 170/110 160/110 120/100 120/110 130/90 130/90 PULSE 80
  • 5. BLOOD COUNT TEST • Haemoglobin : 13.6g/dL • Platelets : 1,68,000 Differential leukocyte count • Lymphocytes : 26% • Basophils : 0% • Eosinophils : 1% • Monocytes : 2%
  • 6. RENAL FUNCTION TEST • Urea : 22 mg% • Serum Creatinine : 1.2 mg%
  • 7. ELECTROLYTES TEST • Sodium : 123 m.Eq/L • Potassium : 4.8 m.Eq/L • Chloride : 91 m.Eq/L
  • 8. OTHER INVESTIGATIONS • Chest X ray • CT scan • EEG
  • 9. ASSESSMENT Based on Subjective and Objective evidence the patient was assessed with “HEAD INJURY with EPILEPSY “ and “HYPERTENSION”
  • 10. GOALS OF TREATMENT • To releive signs and symptoms • To control or reduce the frequency and severity of seizures • To improve the patient compliance • Maintaining or restoring quality of life
  • 11. DRUG CHART BRAND NAME GENERIC NAME FREQ DOSE 2/11 3/11 4/11 5/11 6/11 T.Leripril Levetiraceta m 1-0-1 500mg yes yes yes yes yes T.Eptoin Phenytoin 1-1-1 100mg yes yes yes yes yes T.Amlodipine Amlodipine 1-0-1 5mg yes yes yes yes yes Inj.Ceftriaxone Ceftriaxone 1-0-1 1gm yes yes yes yes - T.Paracetamol Acetaminop hen 1-1-1 600mg yes yes yes yes - T.Cusena Docusate Na+Senna 0-0-2 100+80m g yes yes yes - - IVF NS Normal saline SOS 500ml - yes yes Yes yes T.Hifenac.MR Aceclofenac +Paracetamo l 1-0-1 100+650 mg - - - yes yes T.Nitrofurantoi Nitrofurantoi 1-0-1 100mg - - - - yes
  • 12. DRUG INTERACTIONS • Amlodipine + Phenytoin Amlodipine will increase the level or effect of phenytoin by affecting hepatic /intestinal enzyme CYP3A4 metabolism. • Levetiracetam + Acetaminophen Levetiracetam decreases levels of acetaminophen by increasing metabolism. • Phenytoin + Acetaminophen Phenytoin decreases levels of acetaminophen by increasing metabolism
  • 13. PHARMACIST INTERVENTION • No proper treatment is given to releive cough and expectoration. • Drug duplication is found (paracetamol and T.Hifenac • No proper inference is given regarding investigations done like chest x ray and EEG.
  • 14. PATIENT COUNSELLING • Take medications regularly and properly as indicated. • Avoid more salt intake into your diet. • Drink plenty of water to keep body hydrated. • Get enough sleep. • Intake Ketogenic diet which involces low in carbohydrates and high in protein and fats. • Try relaxation or slow breathing exercises when anxious or if you begin to hyperventilate. • Avoid white products like white sugar,table salt,white rice • Take Epsom salt bath (2/3 times per week) • Do exerises regularly like walking for 45mins but stop and rest if you feel tired • Manage stress and avoid stressful situstions.